61 related articles for article (PubMed ID: 9864273)
1. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of H-bonding probes of alpha7 nAChR agonist selectivity.
Wang J; Papke RL; Horenstein NA
Bioorg Med Chem Lett; 2009 Jan; 19(2):474-6. PubMed ID: 19081250
[TBL] [Abstract][Full Text] [Related]
3. Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.
Stevens KE; Cornejo B; Adams CE; Zheng L; Yonchek J; Hoffman KL; Christians U; Kem WR
Brain Res; 2010 Sep; 1352():140-6. PubMed ID: 20599427
[TBL] [Abstract][Full Text] [Related]
4. Initial phase 2 trial of a nicotinic agonist in schizophrenia.
Freedman R; Olincy A; Buchanan RW; Harris JG; Gold JM; Johnson L; Allensworth D; Guzman-Bonilla A; Clement B; Ball MP; Kutnick J; Pender V; Martin LF; Stevens KE; Wagner BD; Zerbe GO; Soti F; Kem WR
Am J Psychiatry; 2008 Aug; 165(8):1040-7. PubMed ID: 18381905
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the Nicotinic Receptor Toxin Anabaseine in a
Kem WR; Rocca JR; Johnson JV; Junoy J
Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668866
[TBL] [Abstract][Full Text] [Related]
6. New Pyridyl and Dihydroisoquinoline Alkaloids Isolated from the Chevron Nemertean
Kem WR; Soti F; Rocca JR; Johnson JV
Mar Drugs; 2024 Mar; 22(4):. PubMed ID: 38667758
[TBL] [Abstract][Full Text] [Related]
7. The Alpha 7 Nicotinic Acetylcholine Receptor Does Not Affect Neonatal Brain Injury.
Hammarlund ME; Ek CJ; Akar S; Karlsson A; Pattanaik B; Mjörnstedt F; Svedin P; Ardalan M; Rocha-Ferreira E; Mallard C; Johansson ME
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009570
[TBL] [Abstract][Full Text] [Related]
8. The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db/db mice.
Meng Q; Chepurny OG; Leech CA; Pruekprasert N; Molnar ME; Collier JJ; Cooney RN; Holz GG
Diabetes Obes Metab; 2022 Jul; 24(7):1255-1266. PubMed ID: 35293666
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.
Xie H; Yepuri N; Meng Q; Dhawan R; Leech CA; Chepurny OG; Holz GG; Cooney RN
Rev Endocr Metab Disord; 2020 Dec; 21(4):431-447. PubMed ID: 32851581
[TBL] [Abstract][Full Text] [Related]
10. α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future.
Terry AV; Callahan PM
Neuropharmacology; 2020 Jun; 170():108053. PubMed ID: 32188568
[TBL] [Abstract][Full Text] [Related]
11. Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling.
Papke RL; Lindstrom JM
Neuropharmacology; 2020 May; 168():108021. PubMed ID: 32146229
[TBL] [Abstract][Full Text] [Related]
12. Distinct Roles of α7 nAChRs in Antigen-Presenting Cells and CD4
Mashimo M; Komori M; Matsui YY; Murase MX; Fujii T; Takeshima S; Okuyama H; Ono S; Moriwaki Y; Misawa H; Kawashima K
Front Immunol; 2019; 10():1102. PubMed ID: 31214160
[TBL] [Abstract][Full Text] [Related]
13. Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant
Stokes C; Garai S; Kulkarni AR; Cantwell LN; Noviello CM; Hibbs RE; Horenstein NA; Abboud KA; Thakur GA; Papke RL
J Pharmacol Exp Ther; 2019 Aug; 370(2):252-268. PubMed ID: 31175218
[TBL] [Abstract][Full Text] [Related]
14. GTS-21 has cell-specific anti-inflammatory effects independent of α7 nicotinic acetylcholine receptors.
Garg BK; Loring RH
PLoS One; 2019; 14(4):e0214942. PubMed ID: 30947238
[TBL] [Abstract][Full Text] [Related]
15. The effect of the cholinergic anti-inflammatory pathway on collagen-induced arthritis involves the modulation of dendritic cell differentiation.
Liu D; Li T; Luo H; Zuo X; Liu S; Wu S
Arthritis Res Ther; 2018 Nov; 20(1):263. PubMed ID: 30486874
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic modulation of the immune system presents new approaches for treating inflammation.
Hoover DB
Pharmacol Ther; 2017 Nov; 179():1-16. PubMed ID: 28529069
[TBL] [Abstract][Full Text] [Related]
17. Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.
Lewis AS; van Schalkwyk GI; Bloch MH
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():45-53. PubMed ID: 28065843
[TBL] [Abstract][Full Text] [Related]
18. α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit.
Townsend M; Whyment A; Walczak JS; Jeggo R; van den Top M; Flood DG; Leventhal L; Patzke H; Koenig G
J Neurophysiol; 2016 Dec; 116(6):2663-2675. PubMed ID: 27655963
[TBL] [Abstract][Full Text] [Related]
19. Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.
Horenstein NA; Papke RL; Kulkarni AR; Chaturbhuj GU; Stokes C; Manther K; Thakur GA
J Biol Chem; 2016 Mar; 291(10):5049-67. PubMed ID: 26742843
[TBL] [Abstract][Full Text] [Related]
20. Modulation of aggressive behavior in mice by nicotinic receptor subtypes.
Lewis AS; Mineur YS; Smith PH; Cahuzac ELM; Picciotto MR
Biochem Pharmacol; 2015 Oct; 97(4):488-497. PubMed ID: 26212554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
